ORGO
Organogenesis Holdings Inc
NASDAQ: ORGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.59
+0.00% today
Updated 2026-05-27
Market cap
$319.11M
P/E ratio
—
P/S ratio
0.62x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$2 – $7
Volume
1.7M
Organogenesis Holdings Inc (ORGO) Insider transactions
Net insider activity
Net buying (3,405,435 shares)
Buy transactions
45
Sell transactions
55
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-09 | LEIBOWITZ, ARTHUR S | Director | Buy | 5,000 | $2.68 | $13405.00 |
| 2026-03-09 | DRISCOLL, MICHAEL JOSEPH | Director | Buy | 10,000 | $2.67 | $26688.00 |
| 2026-03-01 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 700 | $3.21 | $2247.00 |
| 2026-02-18 | QUINTERO, GILBERTO | Director | Buy | 48,828 | — | — |
| 2026-02-18 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Buy | 23,162 | — | — |
| 2026-02-18 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Buy | 40,625 | — | — |
| 2026-02-18 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Buy | 11,330 | — | — |
| 2026-02-18 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Buy | 11,218 | — | — |
| 2026-02-18 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Sale | 3,778 | $3.84 | $14507.52 |
| 2026-02-18 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Sale | 3,741 | $3.84 | $14365.44 |
| 2026-02-18 | LUSTIG, GARRETT | Director | Buy | 48,828 | — | — |
| 2026-02-18 | LEIBOWITZ, ARTHUR S | Director | Buy | 48,828 | — | — |
| 2026-02-18 | KORFIN, MICHELE ILENE | Director | Buy | 48,828 | — | — |
| 2026-02-18 | GROW, BRIAN | Chief Commercial Officer | Buy | 133,630 | — | — |
| 2026-02-18 | GROW, BRIAN | Chief Commercial Officer | Buy | 234,375 | — | — |
| 2026-02-18 | GROW, BRIAN | Chief Commercial Officer | Buy | 48,818 | — | — |
| 2026-02-18 | GROW, BRIAN | Chief Commercial Officer | Buy | 48,330 | — | — |
| 2026-02-18 | GROW, BRIAN | Chief Commercial Officer | Sale | 11,887 | $3.84 | $45646.08 |
| 2026-02-18 | GROW, BRIAN | Chief Commercial Officer | Sale | 11,768 | $3.84 | $45189.12 |
| 2026-02-18 | GILLHEENEY, GARY S. | Director, President and CEO | Buy | 507,795 | — | — |
| 2026-02-18 | GILLHEENEY, GARY S. | Director, President and CEO | Buy | 890,625 | — | — |
| 2026-02-18 | GILLHEENEY, GARY S. | Director, President and CEO | Buy | 188,856 | — | — |
| 2026-02-18 | GILLHEENEY, GARY S. | Director, President and CEO | Buy | 186,968 | — | — |
| 2026-02-18 | GILLHEENEY, GARY S. | Director, President and CEO | Sale | 91,311 | $3.84 | $350634.24 |
| 2026-02-18 | GILLHEENEY, GARY S. | Director, President and CEO | Sale | 90,398 | $3.84 | $347128.32 |
| 2026-02-18 | GIACOMIN, JON L | Director | Buy | 48,828 | — | — |
| 2026-02-18 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Buy | 115,812 | — | — |
| 2026-02-18 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Buy | 203,125 | — | — |
| 2026-02-18 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Buy | 43,212 | — | — |
| 2026-02-18 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Buy | 42,780 | — | — |
| 2026-02-18 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Sale | 14,411 | $3.84 | $55338.24 |
| 2026-02-18 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Sale | 14,267 | $3.84 | $54785.28 |
| 2026-02-18 | FRANCISCO, DAVID | Chief Financial Officer | Buy | 111,358 | — | — |
| 2026-02-18 | FRANCISCO, DAVID | Chief Financial Officer | Buy | 195,312 | — | — |
| 2026-02-18 | FRANCISCO, DAVID | Chief Financial Officer | Buy | 44,040 | — | — |
| 2026-02-18 | FRANCISCO, DAVID | Chief Financial Officer | Buy | 43,602 | — | — |
| 2026-02-18 | FRANCISCO, DAVID | Chief Financial Officer | Sale | 14,687 | $3.84 | $56398.08 |
| 2026-02-18 | FRANCISCO, DAVID | Chief Financial Officer | Sale | 14,541 | $3.84 | $55837.44 |
| 2026-02-18 | DURAIBABU, PRATHYUSHA | Director | Buy | 48,828 | — | — |
| 2026-02-18 | DRISCOLL, MICHAEL JOSEPH | Director | Buy | 48,828 | — | — |
| 2026-02-18 | CAVORSI, ROBERT | Vice President, Strategy | Buy | 53,452 | — | — |
| 2026-02-18 | CAVORSI, ROBERT | Vice President, Strategy | Buy | 93,750 | — | — |
| 2026-02-18 | CAVORSI, ROBERT | Vice President, Strategy | Buy | 16,454 | — | — |
| 2026-02-18 | CAVORSI, ROBERT | Vice President, Strategy | Buy | 16,290 | — | — |
| 2026-02-18 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 5,487 | $3.84 | $21070.08 |
| 2026-02-18 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 5,432 | $3.84 | $20858.88 |
| 2026-02-18 | BILBO, PATRICK | Chief Operating Officer | Buy | 120,267 | — | — |
| 2026-02-18 | BILBO, PATRICK | Chief Operating Officer | Buy | 210,937 | — | — |
| 2026-02-18 | BILBO, PATRICK | Chief Operating Officer | Buy | 49,102 | — | — |
| 2026-02-18 | BILBO, PATRICK | Chief Operating Officer | Buy | 48,612 | — | — |
| 2026-02-18 | BILBO, PATRICK | Chief Operating Officer | Sale | 16,375 | $3.84 | $62880.00 |
| 2026-02-18 | BILBO, PATRICK | Chief Operating Officer | Sale | 16,212 | $3.84 | $62254.08 |
| 2026-02-15 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Sale | 9,607 | $3.73 | $35834.11 |
| 2026-02-15 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Sale | 4,100 | $3.73 | $15293.00 |
| 2026-02-15 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Sale | 3,523 | $3.73 | $13140.79 |
| 2026-02-15 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Sale | 1,389 | $3.73 | $5180.97 |
| 2026-02-15 | GROW, BRIAN | Chief Commercial Officer | Sale | 18,910 | $3.73 | $70534.30 |
| 2026-02-15 | GROW, BRIAN | Chief Commercial Officer | Sale | 11,144 | $3.73 | $41567.12 |
| 2026-02-15 | GROW, BRIAN | Chief Commercial Officer | Sale | 10,559 | $3.73 | $39385.07 |
| 2026-02-15 | GROW, BRIAN | Chief Commercial Officer | Sale | 3,346 | $3.73 | $12480.58 |
| 2026-02-15 | GILLHEENEY, GARY S. | Director, President and CEO | Sale | 85,605 | $3.73 | $319306.65 |
| 2026-02-15 | GILLHEENEY, GARY S. | Director, President and CEO | Sale | 82,815 | $3.73 | $308899.95 |
| 2026-02-15 | GILLHEENEY, GARY S. | Director, President and CEO | Sale | 78,646 | $3.73 | $293349.58 |
| 2026-02-15 | GILLHEENEY, GARY S. | Director, President and CEO | Sale | 24,340 | $3.73 | $90788.20 |
| 2026-02-15 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Sale | 24,428 | $3.73 | $91116.44 |
| 2026-02-15 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Sale | 13,510 | $3.73 | $50392.30 |
| 2026-02-15 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Sale | 12,761 | $3.73 | $47598.53 |
| 2026-02-15 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Sale | 4,043 | $3.73 | $15080.39 |
| 2026-02-15 | FRANCISCO, DAVID | Chief Financial Officer | Sale | 21,412 | $3.73 | $79866.76 |
| 2026-02-15 | FRANCISCO, DAVID | Chief Financial Officer | Sale | 13,769 | $3.73 | $51358.37 |
| 2026-02-15 | FRANCISCO, DAVID | Chief Financial Officer | Sale | 13,369 | $3.73 | $49866.37 |
| 2026-02-15 | FRANCISCO, DAVID | Chief Financial Officer | Sale | 3,898 | $3.73 | $14539.54 |
| 2026-02-15 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 6,667 | $3.73 | $24867.91 |
| 2026-02-15 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 5,549 | $3.73 | $20697.77 |
| 2026-02-15 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 5,442 | $3.73 | $20298.66 |
| 2026-02-15 | BILBO, PATRICK | Chief Operating Officer | Sale | 28,331 | $3.73 | $105674.63 |
| 2026-02-15 | BILBO, PATRICK | Chief Operating Officer | Sale | 15,617 | $3.73 | $58251.41 |
| 2026-02-15 | BILBO, PATRICK | Chief Operating Officer | Sale | 15,352 | $3.73 | $57262.96 |
| 2026-02-15 | BILBO, PATRICK | Chief Operating Officer | Sale | 5,114 | $3.73 | $19075.22 |
| 2025-12-16 | NUSSDORF, GLENN H | Director | Sale | 200,000 | $5.14 | $1.03M |
| 2025-11-26 | NUSSDORF, GLENN H | Director, 10% Owner | Sale | 187,957 | $5.29 | $994292.53 |
| 2025-11-25 | NUSSDORF, GLENN H | Director, 10% Owner | Sale | 12,043 | $5.30 | $63827.90 |
| 2025-11-24 | NUSSDORF, GLENN H | Director, 10% Owner | Sale | 100,000 | $5.34 | $534000.00 |
| 2025-08-11 | GROW, BRIAN | Chief Commercial Officer | Sale | 4,060 | — | — |
| 2025-08-11 | GROW, BRIAN | Chief Commercial Officer | Buy | 4,060 | $2.47 | $10028.20 |
| 2025-08-11 | GROW, BRIAN | Chief Commercial Officer | Sale | 2,173 | $4.62 | $10028.40 |
| 2025-07-16 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 360 | $4.47 | $1607.40 |
| 2025-06-10 | NUSSDORF, GLENN H | Director, 10% Owner | Sale | 18,620 | $3.56 | $66255.55 |
| 2025-06-09 | NUSSDORF, GLENN H | Director, 10% Owner | Sale | 4,156 | $3.50 | $14547.25 |
| 2025-06-06 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Buy | 9,022 | $2.99 | $26948.71 |
| 2025-06-05 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Buy | 142,379 | $2.91 | $413625.23 |
| 2025-06-04 | FREEDMAN, LORI | Chief Admin. and Legal Officer | Buy | 100,863 | $2.82 | $284716.08 |
| 2025-05-15 | NUSSDORF, GLENN H | Director, 10% Owner | Buy | 107,494 | $2.99 | $320998.58 |
| 2025-05-14 | NUSSDORF, GLENN H | Director, 10% Owner | Buy | 251,001 | $3.09 | $775040.89 |
| 2025-03-09 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 210 | $5.16 | $1083.60 |
| 2025-03-09 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 61 | $5.16 | $314.76 |
| 2025-03-04 | DRISCOLL, MICHAEL JOSEPH | Director | Sale | 25,000 | $5.10 | $127535.00 |
| 2025-03-01 | CAVORSI, ROBERT | Vice President, Strategy | Sale | 667 | $6.21 | $4142.07 |
| 2025-02-19 | QUINTERO, GILBERTO | Director | Buy | 49,575 | — | — |
| 2025-02-19 | MONTECALVO, ANTONIO S. | Vice President, Health Policy | Buy | 43,956 | — | — |
Frequently asked questions
Are ORGO insiders buying or selling?
Over the transactions on record, ORGO insiders have been net sellers, with about $6.01M in stock sold across 55 sales, against 8 open-market purchases.
Does insider selling at ORGO mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which ORGO insiders are selling the most?
Recent selling is concentrated in a few names. NUSSDORF, GLENN H accounts for the largest share on record, with about $2.70M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.